Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 4 uppsatser.

Objetivo: Até 10% dos casos de câncer de mama estão associados com uma síndrome genética de predisposição ao câncer. A identificação de possíveis portadores dessas síndromes e o consequente encaminhamento para aconselhamento genético permitem a adoção de estratégias direcionadas de prevenção e rastreamento capazes de diminuir morbidade e mortalidade. O objetivo do presente estudo foi avaliar a proporção de pacientes com câncer de mama atendidos no Hospital Universitário de Santa Maria (HUSM) que necessitariam ser encaminhados para avaliação genética. Métodos: Pacientes com câncer de mama que iniciaram tratamento oncológico no HUSM durante o ano de 2014 foram considerados elegíveis. Uma entrevista foi conduzida com cada paciente para coleta de dados e exame físico dirigido. O questionário FSH-7 (Family Story Screening 7) e os critérios do NCCN (National Comprehensive Cancer Network) foram utilizados para identificar os pacientes que deveriam ser encaminhados para avaliação genética. Estes pacientes foram então avaliados quanto à indicação de teste genético - de acordo com as recomendações do NCCN para teste genético – e à probabilidade de mutações nos genes BRCA1 e BRCA2 através de modelos de predição de risco (BOADICEA, Penn II, sistema de escore de Manchester e tabelas da Myriad). Resultados: Dentre os 114 participantes do estudo, 65 (57%) preenchiam critérios de encaminhamento para avaliação genética de acordo com as diretrizes do NCCN. O questionário FHS-7 apresentou uma sensibilidade de 90% para identificar estes pacientes, com uma especificidade de 85%. A presença de história pessoal ou familiar de câncer de mama antes dos 50 anos foi o critério mais comum para indicar avaliação genética. Em relação aos testes genéticos, 52 pacientes (45%) deveriam ser testados para mutações nos genes BRCA1 e BRCA2 e 4 pacientes (3,5%) possuíam indicação de teste para mutações em TP53, de acordo com as recomendações do NCCN. Utilizando os modelos de predição de risco, 10,2% a 57,1% dos pacientes apresentavam uma probabilidade ≥ 10% de mutações em BRCA1 ou BRCA2. Conclusão: Este estudo revelou que a maioria dos pacientes com câncer de mama atendidos no HUSM possui indicação de encaminhamento para avaliação genética. A utilização de um questionário simples e rápido poderia identificar 90% destes pacientes. / Objective: Up to 10% of breast cancers are associated with a hereditary cancer syndrome. The identification of possible carriers of these syndromes and the subsequent referral for genetic counselling allow the adoption of tailored screening and prevention strategies capable of reducing morbidity and mortality. The aim of this study is to assess the proportion of patients with breast cancer treated at the University Hospital of Santa Maria (HUSM) that would need to be referred for genetic evaluation. Methods: Breast cancer patients who began cancer treatment at HUSM during the year 2014 were eligible. An interview was conducted with each patient for data collection and targeted physical examination. The FSH-7 (Family Story Screening 7) questionnaire and the NCCN (National Comprehensive Cancer Network) criteria were used to identify patients who should be referred for genetic evaluation. Then these patients were assessed for genetic testing criteria - according to the NCCN recommendations for genetic testing - and the likelihood of BRCA1 and BRCA2 mutations through risk prediction models (BOADICEA, Penn II, Manchester score system and Myriad tables). Results: Among the 114 study participants, 65 (57%) meet referral criteria for genetic evaluation according to the NCCN guidelines. The FHS-7 questionnaire showed a sensitivity of 90% to identify such patients with a specificity of 85%. The presence of personal or family history of breast cancer before age 50 was the most common criteria to indicate genetic evaluation. With respect to genetic testing, 52 patients (45%) should be tested for BRCA1 and BRCA2 mutations and 4 patients (3.5%) had test indication for TP53 mutations in accordance with the recommendations of the NCCN. Using risk prediction models, 10.2% to 57.1% of patients had a BRCA1 or BRCA2 mutations probability ≥ 10%. Conclusion: This study showed that most of the patients with breast cancer treated at HUSM have referral indication for genetic evaluation. The use of a fast and simple questionnaire could identify 90% of these patients.

Objetivo: Até 10% dos casos de câncer de mama estão associados com uma síndrome genética de predisposição ao câncer. A identificação de possíveis portadores dessas síndromes e o consequente encaminhamento para aconselhamento genético permitem a adoção de estratégias direcionadas de prevenção e rastreamento capazes de diminuir morbidade e mortalidade. O objetivo do presente estudo foi avaliar a proporção de pacientes com câncer de mama atendidos no Hospital Universitário de Santa Maria (HUSM) que necessitariam ser encaminhados para avaliação genética. Métodos: Pacientes com câncer de mama que iniciaram tratamento oncológico no HUSM durante o ano de 2014 foram considerados elegíveis. Uma entrevista foi conduzida com cada paciente para coleta de dados e exame físico dirigido. O questionário FSH-7 (Family Story Screening 7) e os critérios do NCCN (National Comprehensive Cancer Network) foram utilizados para identificar os pacientes que deveriam ser encaminhados para avaliação genética. Estes pacientes foram então avaliados quanto à indicação de teste genético - de acordo com as recomendações do NCCN para teste genético – e à probabilidade de mutações nos genes BRCA1 e BRCA2 através de modelos de predição de risco (BOADICEA, Penn II, sistema de escore de Manchester e tabelas da Myriad). Resultados: Dentre os 114 participantes do estudo, 65 (57%) preenchiam critérios de encaminhamento para avaliação genética de acordo com as diretrizes do NCCN. O questionário FHS-7 apresentou uma sensibilidade de 90% para identificar estes pacientes, com uma especificidade de 85%. A presença de história pessoal ou familiar de câncer de mama antes dos 50 anos foi o critério mais comum para indicar avaliação genética. Em relação aos testes genéticos, 52 pacientes (45%) deveriam ser testados para mutações nos genes BRCA1 e BRCA2 e 4 pacientes (3,5%) possuíam indicação de teste para mutações em TP53, de acordo com as recomendações do NCCN. Utilizando os modelos de predição de risco, 10,2% a 57,1% dos pacientes apresentavam uma probabilidade ≥ 10% de mutações em BRCA1 ou BRCA2. Conclusão: Este estudo revelou que a maioria dos pacientes com câncer de mama atendidos no HUSM possui indicação de encaminhamento para avaliação genética. A utilização de um questionário simples e rápido poderia identificar 90% destes pacientes. / Objective: Up to 10% of breast cancers are associated with a hereditary cancer syndrome. The identification of possible carriers of these syndromes and the subsequent referral for genetic counselling allow the adoption of tailored screening and prevention strategies capable of reducing morbidity and mortality. The aim of this study is to assess the proportion of patients with breast cancer treated at the University Hospital of Santa Maria (HUSM) that would need to be referred for genetic evaluation. Methods: Breast cancer patients who began cancer treatment at HUSM during the year 2014 were eligible. An interview was conducted with each patient for data collection and targeted physical examination. The FSH-7 (Family Story Screening 7) questionnaire and the NCCN (National Comprehensive Cancer Network) criteria were used to identify patients who should be referred for genetic evaluation. Then these patients were assessed for genetic testing criteria - according to the NCCN recommendations for genetic testing - and the likelihood of BRCA1 and BRCA2 mutations through risk prediction models (BOADICEA, Penn II, Manchester score system and Myriad tables). Results: Among the 114 study participants, 65 (57%) meet referral criteria for genetic evaluation according to the NCCN guidelines. The FHS-7 questionnaire showed a sensitivity of 90% to identify such patients with a specificity of 85%. The presence of personal or family history of breast cancer before age 50 was the most common criteria to indicate genetic evaluation. With respect to genetic testing, 52 patients (45%) should be tested for BRCA1 and BRCA2 mutations and 4 patients (3.5%) had test indication for TP53 mutations in accordance with the recommendations of the NCCN. Using risk prediction models, 10.2% to 57.1% of patients had a BRCA1 or BRCA2 mutations probability ≥ 10%. Conclusion: This study showed that most of the patients with breast cancer treated at HUSM have referral indication for genetic evaluation. The use of a fast and simple questionnaire could identify 90% of these patients.

In the paper [HSS] Herrlich, Salicrup and Strecker were able to show that Kuratowski / Mrowka's Theorem concerning compactness for topological spaces could be applied to a wider setting. In this dissertation, which is based on the paper [F subscript 1], we interpret Kuratowski / Mrowka's result in the category R-Mod. Chapter One deals mainly with the preliminary definitions and results and we also show that there is a 1-1 correspondence between torsion theories and standard factorisation systems. In Chapter Two we, obtain for every torsion theory T, a theory of T-compactness which is an extension of the definition of compactness found in [HSS]. We then obtain a characterisation of T-compactness under certain conditions on the ring R and torsion theory T. In Chapter Three we examine the class of T-compact R-modules more closely when the ring R is T-hereditary and T-noetherian. We also obtain further characterisation of T-compactness under these additional conditions. In Chapter Four we show that many topological results have analogues in R-Mod. / Mathematical Sciences / M. Sc. (Mathematics)

The study and recognition of graph families (or graph properties) is an essential part of combinatorics. Graph colouring is another fundamental concept of graph theory that can be looked at, in large part, as the recognition of a family of graphs that are colourable according to certain rules. In this thesis, we study additive induced-hereditary families, and some generalisations, from a colouring perspective. Our main results are: · Additive induced-hereditary families are uniquely factorisable into irreducible families. · If <i>P</i> and <i>Q</i> are additive induced-hereditary graph families, then (<i>P</i>,<i>Q</i>)-COLOURING is NP-hard, with the exception of GRAPH 2-COLOURING. Moreover, with the same exception, (<i>P</i>,<i>Q</i>)-COLOURING is NP-complete iff <i>P</i>- and <i>Q</i>-RECOGNITION are both in NP. This proves a 1997 conjecture of Kratochvíl and Schiermeyer. We also provide generalisations to somewhat larger families. Other results that we prove include: · a characterisation of the minimal forbidden subgraphs of a hereditary property in terms of its minimal forbidden induced-subgraphs, and <i>vice versa</i>; · extensions of Mihók's construction of uniquely colourable graphs, and Scheinerman's characterisations of compositivity, to disjoint compositive properties; · an induced-hereditary property has at least two factorisations into arbitrary irreducible properties, with an explicitly described set of exceptions; · if <i>G</i> is a generating set for <i>A</i> &#959; <i>B</i>, where <i>A</i> and <i>B</i> are indiscompositive, then we can extract generating sets for <i>A</i> and <i>B</i> using a <i>greedy algorithm</i>.

The study and recognition of graph families (or graph properties) is an essential part of combinatorics. Graph colouring is another fundamental concept of graph theory that can be looked at, in large part, as the recognition of a family of graphs that are colourable according to certain rules. In this thesis, we study additive induced-hereditary families, and some generalisations, from a colouring perspective. Our main results are: · Additive induced-hereditary families are uniquely factorisable into irreducible families. · If <i>P</i> and <i>Q</i> are additive induced-hereditary graph families, then (<i>P</i>,<i>Q</i>)-COLOURING is NP-hard, with the exception of GRAPH 2-COLOURING. Moreover, with the same exception, (<i>P</i>,<i>Q</i>)-COLOURING is NP-complete iff <i>P</i>- and <i>Q</i>-RECOGNITION are both in NP. This proves a 1997 conjecture of Kratochvíl and Schiermeyer. We also provide generalisations to somewhat larger families. Other results that we prove include: · a characterisation of the minimal forbidden subgraphs of a hereditary property in terms of its minimal forbidden induced-subgraphs, and <i>vice versa</i>; · extensions of Mihók's construction of uniquely colourable graphs, and Scheinerman's characterisations of compositivity, to disjoint compositive properties; · an induced-hereditary property has at least two factorisations into arbitrary irreducible properties, with an explicitly described set of exceptions; · if <i>G</i> is a generating set for <i>A</i> &#959; <i>B</i>, where <i>A</i> and <i>B</i> are indiscompositive, then we can extract generating sets for <i>A</i> and <i>B</i> using a <i>greedy algorithm</i>.

In the paper [HSS] Herrlich, Salicrup and Strecker were able to show that Kuratowski / Mrowka's Theorem concerning compactness for topological spaces could be applied to a wider setting. In this dissertation, which is based on the paper [F subscript 1], we interpret Kuratowski / Mrowka's result in the category R-Mod. Chapter One deals mainly with the preliminary definitions and results and we also show that there is a 1-1 correspondence between torsion theories and standard factorisation systems. In Chapter Two we, obtain for every torsion theory T, a theory of T-compactness which is an extension of the definition of compactness found in [HSS]. We then obtain a characterisation of T-compactness under certain conditions on the ring R and torsion theory T. In Chapter Three we examine the class of T-compact R-modules more closely when the ring R is T-hereditary and T-noetherian. We also obtain further characterisation of T-compactness under these additional conditions. In Chapter Four we show that many topological results have analogues in R-Mod. / Mathematical Sciences / M. Sc. (Mathematics)

Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disorder of the tyrosine degradation pathway. The defective fumarylacetoacetate hydrolase enzyme causes the accumulation of upstream metabolites such as fumarylacetoacetate (FAA), maleylacetoacetate (MAA), succinylacetone (SA) and p-hydroxyphenylpyruvic acid (pHPPA). In vitro and in vivo studies showed that the accumulation of these metabolites are detrimental to cell homeostasis, by inducing cell cycle arrest, apoptosis, and endoplasmic reticulum stress, depleting GSH, inhibiting DNA ligase, causing chromosomal instability, etc. For in vivo studies different models of HT1 were developed. Most notably was the fah deficient mouse, whose neonatally lethal phenotype is rescued by the administration of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). Although, this model most closely resembles the human phenotype with elevated tyrosine levels and the development of hepatocellular carcinoma (HCC), the model is not human genome based. Both the in vitro and in vivo studies suggested that DNA repair is affected in HT1. However, it is not yet clear which DNA repair mechanisms are affected and if only protein functionality is affected, or if expression of DNA repair proteins are also affected. Characteristic of HT1 is the high prevalence of HCC and the presence of liver mosaicism. The liver mosaicism observed in HT1 patients are the result of reversion of the inherited mutation to wild-type. The general consensus is that the reversion is the result of a true back mutation. However, the mechanism underlying the back mutation is still unresolved. It was suggested that cancer develops either through a chromosomal instability mutator phenotype, a microsatellite instability mutator phenotype, or a point mutation instability mutator phenotype. In HT1 only chromosomal instability was reported. The aims of this study were to contribute to the understanding of the molecular basis of the genetic mosaicism in hereditary tyrosinemia type 1. More specifically, determine whether baseand nucleotide DNA repair mechanisms are affected and to what extent, and to determine if microsatellite instability is found in HT1. To achieve these aims, a parallel approach was followed: i.e. to develop a HT1 hepatic cell model and to use HT1 related models and HT1 patient material. To assess the molecular basis of the genetic mosaicism in HT1, the comet assay, gene expression assays, microsatellite instability assays, high resolution melting and dideoxy sequencing techniques were employed. Results from the comet assay showed that the HT1 accumulating metabolites, SA and pHPPA, decreased the capacity of cells for base- and nucleotide excision repair. Gene expression assays showed that short term exposure to SA and/or pHPPA do not affect expression of hOGG1 or ERCC1. The expression of these genes were, however, low in HT1 patient samples. Microsatellite instability assays showed allelic imbalance on chromosome 7 of the mouse genome, and microsatellite instability in the lymphocytes of HT1 patients. Although high resolution melt and sequencing results did not reveal any de novo mutations in fah or hprt1, the appearance of de novo mutations on other parts of the genome can not be ruled out. To conclude, results presented in this thesis, for the first time show that in HT1 the initiating proteins of the base- and nucleotide repair mechanisms are affected, the gene expression of DNA repair proteins are low, and microsatellite instability is found in HT1. By contributing to the elucidation of the mechanism underlying the development of HT1-associated HCC, and providing evidence for the development of a mutator phenotype, the results presented in this thesis contributes to the understanding of the molecular mechanisms underlying the genetic mosaicism in HT1. In addition to these contributions, a hypothesis is posited, which suggests that a point mutation instability (PIN) mutator phenotype is the mechanism underlying the mutation reversions seen in HT1. / Thesis (Ph.D. (Biochemistry))--North-West University, Potchefstroom Campus, 2012

The aim was to assess exercise habits, handle the issue condition in patients with hereditary neuropathy and to clarify the possibility of using fitness training in this disease. We managed to show a reduced fitness of patients with hereditary neuropathy and its relationship with the severity of neurologic disability and mobility habits of individuals. The study results also show the positive effect of physical stress on condition of patients with hereditary neuropathy. Powered by TCPDF (www.tcpdf.org)

The main aim of this thesis is to provide a comprehensive account of the development of the institution of slavery in Korea. Slavery was a part of Korean society from its earliest times, and the evidence of this can be found in the penal code of eight provisions enacted by the mythical emperor Kidža, where he for the first time mentioned slavery as a punishment for theft. From this time on it was ceaselessly present in Korean society until its abolition in 1894. The oldest form of slavery as a punishment was gradually supplemented with other ways of how a person could fall into slavery. Individual slavery gradually evolved into hereditary slavery. Despite the fact that slavery was ceaselessly present in Korean society, the character and even the existence of it are still called into question in academic discussions. In the introductory part of my thesis I focused on the very essence of slavery. Afterwards, I gave a brief overview of the characteristics of three typical slave societies i.e. ancient Greece, ancient Rome and the United States of America. Studying the important characteristics of slavery in other slave societies provided the base for a detailed analysis of the connections with the Korean type of slavery. Some of this information confirms the hypothesis that slavery in Korea was...